Transaction · 0000914190-26-000088
TECHBIO-TECHNE Corp
Kelderman Kim
Kelderman Kim, CEO, reported a transaction classified as exercise at BIO-TECHNE Corp involving 26692.000000 shares for an estimated $1270539.20. Reported holdings after the transaction were 89750.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MCEO
- Trade date
- May 05, 2026
- Filing date
- May 07, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TECH price since this filing
Daily closing prices, with the filing date and available return windowsTECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.8%1w ago -2.8%1d ago +0.0%
Returns since7d +0.0%30d -7.7%90d +30.9%180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0000914190-26-000088 Common Stock
- Transaction date
- May 05, 2026 Filed May 07, 2026, 09:22 PM · 2d delay
- Shares
- 26,692 sh $47.60 per share
- Estimated value
- $1.27M Computed from shares × price
- Holdings after
- 89,750 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
Positive filing signal
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Executive Officer
Officer YesDirector Yes10% NoOther No
Footnotes & amended
- F1
Fully exercisable.
- F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F3
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F4
Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
- F5
Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
- F6
Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
- F7
Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F8
8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
- F9
Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
- F10
Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F11
11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
- F12
Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
Related transactions
Same SEC filing0 other transactions
Recent company activity
TECH0 recent txs